Acute confusion Flashcards

1
Q

Define delirium

A

Acute, fluctuating and reversible state of confusion involving an impairment of conscious level (demonstrated by reduced GCS) and often involves psychotic symptoms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What factors suggest delirium over dementia?

A

Sudden change in behaviour

Top 3 suggest delerium

  • Altered level of consciousness (reduced awareness of surroundings, sleep-wake cycle disturbances e.g. daytime drowsiness)
  • Altered perception (e.g. illusions and hallucinations in 30%)
  • Fluctuation of symptoms: worse at night, periods of normality

Others:

  • Altered physical function- Hyper or Hypo (more common) delirium
  • Altered social behaviour- changes in mood and/or emotions (such as fear, paranoia, anxiety, depression, irritability, apathy, anger, or euphoria)
  • Inattention- easily distracted
  • Disorganised thinking- rambling, irrelevant conversations
  • Falling and loss of appetite are often warning signs for delirium.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are causes of delirium?

A

PINCHME?
P- Pain- can worsen delierium? Urinary retention?
IN- Infection like UTI
C-constipation
H- Hydration/Nutrition- eletrolyte imbalances?
M- Medication
E- Environment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Symptoms of hyperactive delirium?

A
  • Agitation
  • Delusions
  • Hallucinations
  • Wandering
  • Aggression
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Symptoms of hypoactive delirium? (Most common type)

A
  • Lethargy
  • Slowness with everyday tasks
  • Excessive sleeping
  • Inattention
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

How would you assess a confused patient?

A
  1. History- ask about onset, nature and course of behaviour change, new illnesses, recent discharges, falls, pain, oral intake, changes in the environment, medications, alcohol, sensory impairment (vision and hearing)
  2. Cognitive assessment- Use GPCOG to assess baseline
  3. Clinical exam:
    - Vital signs (e.g. fever in infection, low SpOin pneumonia, Bms)
    - Level of consciousness (e.g. GCS/AVPU)
    - Evidence of head trauma
    - Sources of infection (e.g. suprapubic tenderness in urinary tract infection)
    - Asterixis (e.g. uraemia/encephalopathy)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

How is a diagnosis of delirium confirmed?

A

Cognitive assessment based on the

  1. Diagnostic and Statistical Manual of Mental Disorders (DSM-5) criteria- disturbance to attention, cognition
  2. The short Confusion Assessment Method (short-CAM)- Need Confusion that has developed suddenly and fluctuates + Inattention, disorganised thinking and altered level of consciousness
  3. The 4A’s test- alertness, cognition, attention, acute/fluctuating changes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Management of delirium in primary care?

A
  1. Correct risk factors - infection, drug, constipation, urinary retention, dehydration + electrolyte imbalance, pain, sensory impairement
  2. Optimise comorbidity treatment e.g. COPD, DMs, Dementia, HF, TD, Parkinsons, Cerebovasc
  3. Advise family/careers- use reorientation strategies
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

List the supportive management/reorientation strategies used in delirium:

A

Reorientation strategies:

  1. Regular (at least three times a day) cues (for example explaining to the person who and where they are).
  2. Easily visible and accurate clocks and calendars.
  3. Continuity of care from carers and nursing staff.
  4. Encouraging visits from family or friends and exposure to familiar objects.

Maintain safe mobility:

  1. Avoid physical restraints such as cot sides.
  2. Encourage walking at least three times a day (provide walking aids if needed) or, if the person is unable to mobilize, try active range of motion exercises.

Normalize the sleep-wake cycle by:

  1. Discouraging napping and encouraging bright light exposure in the daytime.
  2. Encouraging uninterrupted sleep at night with a quiet room and low-level lighting.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What to do if they develop challenging behavior?

A

Address any underlying causes for the behaviour (such as discomfort, thirst, or need for the toilet).
Advise moving the person to a safe, low-stimulation environment (such as a quiet room).
Advise use of verbal and non-verbal de-escalation techniques (such as active listening, effective verbal responding, pictures, and symbols).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is included in a confusion screen?

A
  1. Blood tests:
    - FBC (e.g. infection, anaemia, malignancy)
    - U&Es(e.g. hyponatraemia, hypernatraemia)
    - LFTs(e.g. liver failure with secondary encephalopathy)
    - Coagulation/INR(e.g. intracranial bleeding)
    - TFTs(e.g. hypothyroidism)
    - Calcium(e.g. hypercalcaemia)
    - B12 + folate
    - Glucose (e.g. hypoglycaemia/hyperglycaemia)
    - Blood cultures (e.g. sepsis)
  2. Urinalysis for UTI- A positive urine dipstick without clinical signs isNOTsatisfactoryto diagnose urinary tract infection
  3. Imaging
    - CT head
    - Chest x ray
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the medication options?

A

Both off label
First line: Haloperidol (1 week or less)
- The risks (for example with haloperidol, an increased risk of stroke, transient ischaemic attack, and changes in cognition) and benefits (a small reduction in psychosis, aggression, and agitation)
Second line: Lorazepam
- if haloperidol is contraindicated (for example in people with Parkinson’s disease/parkinsonism, Lewy-body dementia, or a prolonged QT interval)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Haloperidol- MOA and dose

A
  • Type: 1st gen antipsychotic
  • MOA: D2 antagonism
  • Dose: 0.25-0.5mg increase every 2 hours (Lower than that in BNF as per NICE). Max 2mg in 24 houts
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Lorazepam- MOA, Dose, SI

A

Type: Rapid onset, short t1/2, intermediate-acting benzo

MOA: Indirect GabaA agonism, increasing GABA= Decreased neuronal excitability

Dose: 0.5mg-1mg increased after 2 hrs

SI: Daytime drowsiness, Dizziness, Muscle weakness, Ataxia.

CI: Respiratory depression, marked neuromuscular respiratory weakness (including myasthenia gravis), acute pulmonary insufficiency, or sleep apnoea syndrome, evere hepatic impairment (may precipitate encephalopathy).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

How do you differentiate delirium from Wernicke’s encephalopathy?

A

Wernicke’s encephalopathy=

  • Ataxia (unsteady gait)
  • Ophthalmoplegia (Weakness of eye muscles)
  • Nystagmus
  • Confusion
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How do you differentiate delirium from Korsakoff’s syndrome?

A

Korsakoff’s syndrome is wernickes (nystagmus, opthalmoplegia, ataxia) +:

  • Anterograde amnesia (unable to form new memories)
  • Retrograde amnesia (unable to recall past memories)
  • Confabulation (making up new memories)

Overview
marked memory disorder often seen in alcoholics thiamine deficiency causes damage and haemorrhage to the mammillary bodies of the hypothalamus and the medial thalamus in often follows on from untreated Wernicke’s encephalopathy

17
Q

Haloperidol- Contraindications

A
  1. Parkinsons
  2. Lewy body Dementia
  3. Myasthenia gravis
  4. Phaeochromocytoma
  5. QT prolongation, recent MI, heart block, bradycardia
  6. Uncorrected hypoK
18
Q

Haloperidol side effects

A

-SI:
-Extrapyramidal symptoms (such as Parkinsonism, acute dystonias, tardive dyskinesia and akathisia).
- Cardiac= Prolong QT interval (Do ECG first if CVD history)- can cause sudden death
-Neuroleptic malignant syndrome (hyperthermia, muscle rigidity, autonomic instability, and fluctuating consciousness)- Rare life-threatening- mortality 20%without treatment
Hormonal effects -hyperprolactinaemia, which may cause galactorrhoea and gynaecomastia. Very rare hypoglycaemia and (SIAD)

Gastrointestinal effects — dry mouth, constipation, nausea, vomiting, loss of appetite, weight changes, and dyspepsia.

Psychiatric effects — agitation, insomnia, and depression.

Convulsions — seizures (the higher the dose, the greater the risk).

Urinary retention.

Visual disturbance — blurred vision and very rarely, precipitation of angle-closure glaucoma.

Venous thromboembolism — cases of pulmonary embolism and deep vein thrombosis.